Holders over time
- ENSG
- ELV
| Quarter | ENSG | ELV |
|---|---|---|
| Q3 2020 | 2 holders, $3.8m | 30 holders, $15.0bn |
| Q4 2020 | 3 holders, $38m | 29 holders, $16.7bn |
| Q1 2021 | 1 holders, $31m | 25 holders, $18.6bn |
| Q2 2021 | none listed holders, n.a. | 30 holders, $19.4bn |
| Q3 2021 | 1 holders, $2.3m | 26 holders, $18.5bn |
| Q4 2021 | 1 holders, $4.8m | 29 holders, $23.3bn |
| Q1 2022 | 1 holders, $6.8m | 31 holders, $23.9bn |
| Q2 2022 | 3 holders, $12m | 32 holders, $23.3bn |
| Q3 2022 | 3 holders, $8.9m | 34 holders, $22.6bn |
| Q4 2022 | 3 holders, $55m | 34 holders, $25.5bn |
| Q1 2023 | 3 holders, $141m | 39 holders, $22.5bn |
| Q2 2023 | 4 holders, $182m | 38 holders, $20.6bn |
| Q3 2023 | 4 holders, $228m | 34 holders, $19.8bn |
| Q4 2023 | 3 holders, $301m | 36 holders, $20.3bn |
| Q1 2024 | 4 holders, $325m | 35 holders, $21.3bn |
| Q2 2024 | 4 holders, $320m | 33 holders, $22.1bn |
| Q3 2024 | 8 holders, $518m | 30 holders, $20.2bn |
| Q4 2024 | 7 holders, $470m | 32 holders, $15.9bn |
| Q1 2025 | 9 holders, $463m | 28 holders, $17.1bn |
| Q2 2025 | 7 holders, $696m | 27 holders, $14.8bn |
| Q3 2025 | 7 holders, $1.2bn | 27 holders, $12.7bn |
| Q4 2025 | 8 holders, $1.5bn | 25 holders, $17.0bn |
| Q1 2026 | 8 holders, $1.8bn | 26 holders, $13.6bn |
| Q2 2026 | 8 holders, $1.4bn | 28 holders, $17.7bn |
Ensign Group Inc
- Holders
- 7
- Reported value
- $1.2bn
- Buyers
- 4
- Sellers
- 3
Breadth +1 among 95 comparable managers.
Elevance Health Inc Formerly
- Holders
- 27
- Reported value
- $12.7bn
- Buyers
- 18
- Sellers
- 9
Breadth +9 among 95 comparable managers.
Who holds both, Q3 2025
Both (6)
Arrowstreet Capital LP, Baillie Gifford & Co, Capital Research Global Investors, First Eagle Investment Management LLC, T. Rowe Price Associates Inc, Wellington Management Group LLP
Only ENSG (1)
Only ELV (21)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Artisan Partners LP, Baupost Group LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, D. E. Shaw & Co., Discovery Capital Management LLC, Dodge & Cox, Harris Associates LP, Invesco Ltd, Janus Henderson Group Ltd, MFS Investment Management, Moore Capital Management LP, Quantbot Technologies LP, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Tudor Investment Corp, Two Sigma Investments LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.